Trial Profile
A multicenter, multinational, randomized, DB [double-blind] controlled study of the efficacy & safety of oral telithromycin 800 mg once QD for 5 days vs azithromycin in the treatment of acute exacerbation of chronic bronchitis in adult outpatients with COPD [chronic obstructive pulmonary disease]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Telithromycin (Primary) ; Azithromycin
- Indications Acute exacerbations of chronic bronchitis; Bacterial infections
- Focus Therapeutic Use
- Sponsors Sanofi
- 09 Oct 2007 New trial record.